Cargando…
Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status
The treatment of patients with human epidermal growth factor receptor 2 (HER2)-negative gastric cancer is a major challenge. Immunotherapy using immune checkpoint inhibitors is a rapidly growing field. In a number of malignancy types it has been demonstrated that patients with mismatch repair defici...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614673/ https://www.ncbi.nlm.nih.gov/pubmed/31423245 http://dx.doi.org/10.3892/ol.2019.10513 |